Delta 9 Cannabis: Top 10 Undervalued Drug Manufacturers Industry Stocks (DN)
Delta 9 Cannabis is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| AH | Aleafia Health | 0.02 | 0.05 | 0.03 (150.4%) | 7.7 | 0.0 | 0.0 | |
| NDVA | Indiva | 0.04 | 0.08 | 0.05 (135.7%) | 402504 | 5.2 | 0.0 | 0.0 |
| CWEB | Charlottes Web Holdings | 0.38 | 0.79 | 0.41 (109.7%) | 93407 | 57.3 | 0.0 | 0.0 |
| ROMJ | Rubicon Organics | 0.46 | 0.95 | 0.49 (107.6%) | 14369 | 26.2 | 0.0 | 0.0 |
| NU | NeutriSci International | 0.01 | 0.01 | 0.00 (99.7%) | 22794 | 0.9 | 0.0 | 0.0 |
| VPH | Valeo Pharma | 0.32 | 0.62 | 0.30 (96.8%) | 35898 | 26.4 | 0.0 | 0.0 |
| SBBC | Simply Better Brands | 0.27 | 0.52 | 0.25 (92.3%) | 42172 | 15.2 | 0.0 | 0.0 |
| DN | Delta 9 Cannabis | 0.04 | 0.08 | 0.04 (88.8%) | 263438 | 6.4 | 0.0 | 0.0 |
| LFST | Lifeist Wellness | 0.02 | 0.04 | 0.02 (84.9%) | 543234 | 8.8 | 0.0 | 0.0 |
| ACB | Aurora Cannabis | 0.65 | 1.04 | 0.39 (59.6%) | 833567 | 229.8 | 0.0 | 0.0 |
All data provided as-at market close September 03, 2023.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Delta 9 Cannabis
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs. Stocks in this category are held primarily for capital appreciation.
Delta 9 Cannabis is listed under DN on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
